Home » Topics » Regulatory

Regulatory
RSS

FDA approves ciprofloxacin for treatment of postexposure inhalational anthrax

Sep. 7, 2000

Use of AII receptor antagonists in prevention, treatment of AMI

Sep. 7, 2000

New use for topiramate: bulimia nervosa Rx

Sep. 6, 2000

Anticonvulsants for cluster headache

Sep. 6, 2000

Topiramate has beneficial effects in transformed migraine

Sep. 6, 2000

Tripedia receives FDA approval for use in the entire DTP immunization series

Sep. 6, 2000

Taxotere combination therapy approved in E.U. for treatment of advanced breast cancer

Sep. 5, 2000

Zometa approved in Canada for treatment of tumor-induced hypercalcemia

Aug. 31, 2000

Tablet form of Rapamune receives FDA approval

Aug. 30, 2000

New findings on an old drug: metformin

Aug. 3, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 21, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...